Rearrangements involving the mixed lineage leukemia (MLL) gene (also known as the KMT2A gene), which occur in approximately 5–10% of overall childhood ALL cases, are common adverse prognostic factors of ALL [6,7]. Here, KMT2A is linked to acute lymphoblastic leukemia.